SEC Form 4 · accession 0001209191-18-034472
Protagonist Therapeutics, Inc · PTGX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Samuel R Saks
Officer — Chief Development Officer
Period of report
May 31, 2018
Accepted (ET)
May 31, 2018 · 6:29 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001377121
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $7.28 | May 31, 2018 | A | 50,000 | A | — | May 30, 2028 | Common Stock | 50,000 | 50,000 | D |
Explanation of responses
- F1The option vests over a four-year period, with 1/4th of the shares subject to the option vesting on the one year anniversary of the vesting commencement date of May 21, 2018, and 1/36th of the remaining shares subject to the option vesting each month.